Tilray Brands (TLRY) Shares Outstanding (Weighted Average) (2017 - 2025)

Tilray Brands (TLRY) reported Shares Outstanding (Weighted Average) of $1.1 billion for Q3 2025, up 16976.37% on a YoY basis from N/an in Q3 2024, and up 170663.71% quarter-over-quarter from $620900.0 in Q2 2025.

Tilray Brands (TLRY) Shares Outstanding (Weighted Average) (2017 - 2025) Analysis & Trends

Tilray Brands has reported Shares Outstanding (Weighted Average) for 9 years, with the latest figure at $1.1 billion in Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 16976.37% year-over-year to $1.1 billion; the trailing twelve-month figure through Aug 2025 stood at $1.1 billion (up 16976.37% YoY), and the FY2025 full-year result was $890.3 million, up 14239.28% from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 stood at $1.1 billion, up from $620900.0 in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $1.1 billion in Q3 2025, with the low at $620900.0 in Q2 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $393.8 million across 5 years, with a median of $454.8 million in 2021.
  • Annual changes were most pronounced in 2024 — Shares Outstanding (Weighted Average) slumped 99.1% — and 2025, when it soared 16976.37%.
  • Tilray Brands' Shares Outstanding (Weighted Average) stood at $454.8 million in 2021, then increased by 29.53% to $589.1 million in 2022, then increased by 24.05% to $730.8 million in 2023, then slumped by 88.16% to $86.5 million in 2024, then jumped by 1125.78% to $1.1 billion in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $1.1 billion (Q3 2025), $620900.0 (Q2 2025), and $90.8 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Tilray Brands - - 54.95 Mn -

Historic Data

Download Data
DateValue
Aug 31, 2025 1.06 Bn
May 31, 2025 620,900.00
Feb 28, 2025 90.83 Mn
Nov 30, 2024 86.50 Mn
Aug 31, 2024 6.21 Mn
May 31, 2024 6.21 Mn
Feb 29, 2024 6.21 Mn
Nov 30, 2023 730.77 Mn
Aug 31, 2023 691.19 Mn
May 31, 2023 617.98 Mn
Feb 28, 2023 615.53 Mn
Nov 30, 2022 589.11 Mn
Aug 31, 2022 575.30 Mn
May 31, 2022 481.22 Mn
Feb 28, 2022 485.67 Mn
Nov 30, 2021 454.80 Mn
Aug 31, 2021 449.40 Mn
May 31, 2021 269.55 Mn
Feb 28, 2021 265.40 Mn
Nov 30, 2020 242.21 Mn